Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Baird Medical and ExcelFin Acquisition Corp Announce Effectiveness of Registration Statement 2024-09-06 05:23
A Small Step towards a Big Mission! World's First! UltraDx Received First Clinical Approval of Single-Molecule Analyzer, in China 2024-09-05 20:35
Medera Inc. to be Listed on NASDAQ Through a Merger Agreement with Keen Vision Acquisition Corporation 2024-09-05 20:00
Breakthrough Therapy designation for Sanbexin sublingual tablets granted by the United States Food and Drug Administration 2024-09-05 13:49
Grand launch | Sanyou Bio monkeypox antibody made a great breakthrough 2024-09-05 08:00
Harrison.ai launches world leading AI model to transform healthcare 2024-09-04 21:30
Samyang Corporation Completes Specialty Plant, Establishes Korea's Largest Allulose Production Facility 2024-09-04 20:30
LakeShore Biopharma Announces Leadership Transitions 2024-09-04 20:00
Waterdrop Inc. Announces Second Quarter 2024 Unaudited Financial Results and a Special Cash Dividend 2024-09-04 18:18
HKBU develops Chinese medicine for ulcerative colitis approved by National Medical Products Administration for clinical trial 2024-09-04 15:13
Acepodia Enters Strategic Clinical Collaboration with Pfizer to Accelerate Development of Antibody-Cell Conjugation-Based Cell Therapies in Autoimmune Diseases 2024-09-04 05:00
Immune Phenotyping Identified as Promising Predictive Biomarker by Lunit AI in Biliary Tract Cancer - New publication in CCR 2024-09-03 21:00
Biostar Announces Completion of Patient Recruitment for US Phase 1 Clinical Study of Utidelone Capsule 2024-09-03 20:00
FIT KING's Award-Winning Innovation: The Recovery Pro Full Leg Compression Massage Boots 2024-09-03 20:00
Skyline Therapeutics' Novel Gene Therapy SKG1108 Receives FDA Orphan Drug Designation for Retinitis Pigmentosa 2024-09-03 18:00
QingSong Health Chairman Speaks at Global Ethics Forum in Geneva: Advancing Ethical Leadership in Healthcare 2024-09-03 16:27
GC Biopharma and Hanmi Pharmaceutical Receives IND Clearance for Phase 1/2 Clinical Trial from the U.S. FDA 2024-09-03 15:59
Caliway Announces the Initiation of Subject Recruitment in CBL-514 Phase 2b Study for Dercum's Disease 2024-09-03 15:18
Simcere Zaiming collaborates with TargetRx to introduce a third-generation ALK inhibitor 2024-09-02 20:24
Jacobio Out-licensed KRAS G12C Inhibitor Glecirasib and SHP2 Inhibitor JAB-3312 to Allist in China 2024-08-30 19:34
1 15 16 17 18 19 800